122-103
FINALWashington
Wizards
49-40|L10: 5-5
Philadelphia
76ers
16-62|L10: 4-6
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Washington Wizards
Philadelphia 76ers
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 53-25 | 0.679 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 2/27 | W 16-11 | |
| 2/25 |
| 51-26 |
| 0.662 |
| 1.5 |
| 3 | 48-32 | 0.600 | 6.0 |
| 4 | 45-31 | 0.592 | 7.0 |
| 5 | 43-35 | 0.551 | 10.0 |
| 6 | 82-68 | 0.547 | 7.0 |
| 7 | 36-43 | 0.456 | 17.5 |
| 8 | 36-43 | 0.456 | 17.5 |
| 9 | 32-44 | 0.421 | 20.0 |
| 10 | 28-50 | 0.359 | 25.0 |
| 11 | 24-53 | 0.312 | 28.5 |
| 12 | 21-57 | 0.269 | 32.0 |
| 13 | 16-62 | 0.205 | 37.0 |
| 14 | 14-63 | 0.182 | 38.5 |
| 15 | 0-0 | 0.000 | 14.0 |
| 2/23 | W 96-83 |
| 2/22 | W 94-93 |
| 2/19 | W 114-97 |
| Opponent | Date | Result |
|---|---|---|
| 2/26 | L 90-101 | |
| 2/24 | L 110-130 | |
| 2/21 | L 112-124 | |
| 2/18 | L 85-114 | |
| 2/12 | L 100-105 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 19.0 | 42.1% | 30.6% | 74.9% | |
| 17.6 | 42.7% | 40.4% | 60.2% | |
| 14.2 | 45.4% | 38.1% | 58.0% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 18.0 |
| 45.0% |
| 24.6% |
| 52.1% |
| 17.0 | 40.6% | 22.7% | 69.6% |
| 16.6 | 40.0% | 18.8% | 63.2% |
| Category | PHI Offense | WAS Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #2978.5 ORtg | #5102.7 DRtg | WAS |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #2813.0% | #515.7% | PHI |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #2931.0% | #735.1% | WAS |
| Category | PHI Defense | WAS Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #25107.9 DRtg | #1784.5 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #216.3% | #1411.8% | PHI |
3P% vs AllowedPerimeter defense vs perimeter shooting | #2036.6% | #637.7% | PHI |
